Training Manual for Preventive Malaria - Ministry of Health

More documents

Recommendations

Info

APPENDIX C: ADDENDUM TO ANTENATAL/MATERNITY MONTHLY DATA RETURNS Name of Health Facility________________________________District_______________ Region_______________________Month_________________Year__________________ ANTENATAL RECORD Number INDICATOR Total ANC Attendance First ANC Attendance Second ANC Attendance First dose of IPT (IPT1) Second dose of IPT (IPT2) Third dose of IPT (IPT3) ITN use on First ANC visit ITN use on Second ANC visit All screened in 3 rd . trimester for Hb Primigravidae screened in 3 rd . trimester for Hb Primigravidae with severe anaemia in 3 rd . trimester (Hb
IN STRICT CONFIDENCE Adverse Event Form for SULPHADOXINE/PYRIMETHAMINE IN IPT IN PREGNANT WOMEN IN STRICT CONFIDENCE PATIENT DETAILS Last Name: Other Name(s): Address: Town/City: Region: Date of birth:____/____/___ Age:_____years_____months Weight (kg):_______ Height (m)_______ DRUG DETAILS AILS Is Patient on SP for IPT? Yes No Do not know IPT Schedule Date IPT1 IPT2 IPT3 D DETAILS OF ADVERSE EVENTS ETAILS OF ADVERSE EVENT Date event started:____/____/____ Date event stopped:____/____/____ Adverse reaction observed (please tick all that applies) Vomitting [ ] Nausea [ ] Itching [ ] Skin rashes [ ] Diarrhoea [ ] Headache [ ] Mouth sores [ ] Stomach pains [ ] Dizziness [ ] Insomnia [ ] Dark-coloured urine [ ] Other (please specify): Description of event (Continue on back page if necessary): Treatment or action taken (Continue on back page if necessary): Outcome (please tick all that apply) Death Life Threatening Required / prolonged hospitalisation Permanent disability Congenital anomaly Ongoing Recovered Other outcome (please specify) REPORTER DETAILS S Doctor Pharmacist Nurse Other (please specify) Last Name: Other Name(s): Title Address: Tel No. Email: Signature Date: Please return this form to: YOUR DHMT Forms MAY also be sent to The National Centre for Pharmacovigilance, CTCPT, UGMS, 2 nd Floor Medical Block Building, Korle-Bu Teaching Hospital, Box 4236, Accra, Ghana Tel: 021-675885//779838; Fax: 668219 OR The National Malaria Control Programme, Tel. 021-762031, Accra Please note: Completion of this form is not an admission of causation by, or contribution to the suspected adverse event by the suspected drug(s) or the reporting professional. The information does help to ensure the safety of all pregnant women in Ghana 65
Page 1 and 2:
INTERMITTENT PREVENTIVE TREATMENT (
Page 3 and 4:
curative treatment doses of an effe
Page 5 and 6:
TABLE OF CONTENTS CONTENT PAGE COVE
Page 7 and 8:
INTRODUCTION Background Malaria is
Page 9 and 10:
• Cover doors and windows with wi
Page 11 and 12:
cells. About 1 to 2 weeks later, th
Page 13 and 14: 1.4: INTERACTION BETWEEN HIV/AIDS A
Page 15 and 16: ROLE-PLAY: MALARIA DURING PREGNANCY
Page 17 and 18: 2a.1: FOCUSED ANTENATAL CARE Focuse
Page 19 and 20: 2A.3: SCHEDULING OF VISITS It is re
Page 21 and 22: UNIT 2B COMMUNICATION AND COUNSELLI
Page 23 and 24: 2B.3: BIRTH PREPAREDNESS AND COMPLI
Page 25 and 26: I will make sure she finds out how
Page 27 and 28: i. Explain all procedures/actions a
Page 29 and 30: These effects are caused by malaria
Page 31 and 32: Step 2 ° Give pregnant woman 1 st
Page 33 and 34: ALTERNATIVE MEASURES FOR THOSE WHO
Page 35 and 36: UNIT 4 CASE MANAGEMENT This unit ou
Page 37 and 38: Table: Treatment of Uncomplicated M
Page 39 and 40: Oral Administration Oral Quinine at
Page 41 and 42: CASE STUDY : TREATING A CLIENT WHO
Page 43 and 44: -- Begin treatment for uncomplicate
Page 45 and 46: (If the diluted volume is more than
Page 47 and 48: LEARNING GUIDE FOR TREATMENT OF UNC
Page 49 and 50: 16. If she has any of the danger sy
Page 51 and 52: - % of antenatal clinic staff train
Page 53 and 54: CASE STUDY: RECORD KEEPING Directio
Page 55 and 56: UNIT 5B ADVERSE DRUG REACTION MONIT
Page 57 and 58: 5B.4: MONITORING OF ADVERSE EFFECTS
Page 59 and 60: o Other medical products (drugs, he
Page 61 and 62: Delivery (Maternity) Book This reco
Page 63: Addendum to Midwifery Monthly Retur
Page 67 and 68: APPENDIX F: MONITORING AND EVALUATI
Page 69 and 70: ADD UP TO 20 QUESTIONS 69
Page 71 and 72: C. Check the gestational age of the
Page 73: A. Oedema B. Dark coloured-urine C.
show all

Training Manual for Preventive Malaria - Ministry of Health

Create successful ePaper yourself

Delete template?

Save as template?